More progressive healthcare providers say recent HHS rules banning discrimination against transgender people are raising questions about adequately serving the community.
Hospitals have been holding a lot more meet-and-greets for new hires this year, and it's unclear when those might slow down.
On Oct. 1, Medicaid programs in California and three other states will not fully convert from the ICD-9 to the ICD-10 coding system. Instead, they have received CMS approval to convert claims coded in the new ICD-10 system into ICD-9 codes, and use the older system to calculate payments to...
The Obama administration says it needs more time than expected to evaluate a large-scale test that aims to better manage benefits and care for low-income and disabled Americans. The 12 states participating in the initiative seem willing to stick with it, although the two biggest ones have...
Some say a former hospital CEO's allegation of anticompetitive activity by Partners HealthCare and its electronic health-record vendor points to the broader problem of barriers to EHR interoperability.
Highmark Health reported an operating loss of $171 million during the first six months of the year as losses soared for health plans sold in Affordable Care Act exchanges.
A Federal Reserve interest rate hike could come as soon as this month, but that isn't likely to deter healthcare borrowing. It may even encourage providers to accelerate spending plans to stay ahead of rising rates.
The president of New York-Presbyterian Hospital, Dr. Robert Kelly, quietly stepped down Thursday from his post. The $4.6 billion hospital removed Kelly's biography and his name from its website, where it once appeared prominently among the executive leadership team.
Indianapolis-based Community Health Network has launched a joint venture with management company VillageMD to provide analytics and disease-management services to primary-care physicians.
Two papers published online Wednesday in the New England Journal of Medicine show promising results in the treatment of two rare blood disorders using an experimental therapy developed by Menlo Park, Calif., biopharmaceutical firm Geron Corp.
The first biosimilar medication approved in the U.S. made its way to the market on Thursday, ushering in a new era of competition between such drugs and the original high-cost biologic therapies they emulate.
The Texas hospital that treated the first person diagnosed in the U.S. with Ebola was not adequately prepared for a patient with the deadly virus and stumbled because of communication failures, an independent review released Friday found.